semaglutide for menopausal women Weight loss response to in postmenopausal with and without hormone therapy use A New Study Says That
Description
Implications for Patients in Mesa & Scottsdale, Arizona These regulatory changes may impact treatment plans for patients in Mesa and Scottsdale relying on compounded semaglutide or tirzepatide for weight management

For others, mild changes may come and go based on hydration, diet, or ongoing weight loss

6 in the non-GLP-1 RA group

There were 17 NAION events in the GLP-1 group compared to 6 in the non-GLP-1 RA group

2020 doi: 10.1111/dom.14244

This risk is highest when initiating treatment, adjusting doses, or in patients with pre-existing cardiovascular disease or taking multiple blood pressure medications
